Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Cannabidiol improves symptoms of canine arthritis, study finds
Arthritis affects one in five dogs.

Scientists measure the effect of CBD in dogs diagnosed with the condition. 

Scientists in the United States have discovered that cannabidiol (CBD) can significantly improve the lives of dogs diagnosed with arthritis.

The researchers, from the Baylor College of Medicine in Texas, say their results could pave the way to studying the effects of CBD in humans.

In the study, the scientists first measured the effect of CBD on immune responses associated with arthritis, both in human and murine cells grown in the lab and mouse models. They found that that CBD treatment resulted in reduced production of both inflammatory molecules and immune cells linked to arthritis.

Next, the researchers found that in dogs diagnosed with the condition, CBD treatment significantly improved quality of life as documented by both owner and veterinary assessments. Scientists say their work, published in the journal PAIN, supports future scientific evaluation of CBD for human arthritis.

“We found encouraging results,” said Dr Matthew Halpert, research faculty in the department of pathology and immunology at Baylor. “Nine of the 10 dogs on CBD showed benefits, which remained for two weeks after the treatment stopped. We did not detect alterations in the blood markers we measured, suggesting that, under the conditions of our study, the treatment seems to be safe.”

Arthritis affects one in five dogs, and its prevalence increases as a dog ages, according to Canine Arthritis Management.

Twenty dogs from the Sunset Animal Hospital in Houston were employed for the study. The dogs' owners were given medicine bottles at random, containing either CBD, liposomal CBD, or a placebo. Neither the owner nor the vet knew which treatment each dog was receiving.

The dogs received the treatment each day for four weeks. The vet and the dogs' owners noted the condition of the dogs and whether they noticed any changes in their animal's level of pain, such as changes related to running or gait. The dogs' blood cell count, liver and kidney function were also evaluated before and after treatment.

“We studied dogs because experimental evidence shows that spontaneous models of arthritis, particularly in domesticated canine models, are more appropriate for assessing human arthritis pain treatments than other animal models," said Halpert. "The biological characteristics of arthritis in dogs closely resemble those of the human condition."

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.